Biomedical subjects

L D Haugh

Publications and source records attributed to L D Haugh.

40 records · Page 3Linked to original sources

PubMed1976

Treatment of perennial allergic rhinitis with cromolyn sodium. Double-blind study on 34 adult patients.

A double-blind crossover study was performed on 34 adult patients with perennial allergic rhinitis, using an aqueous solution of 4% cromolyn sodium or a placebo substance six times daily over a 4-wk period with daily documentation of both symptoms and use of symptomatic medications. All patients had markedly positive skin test reactions to at least one antigen. Chemistry screens and IgE serum levels were determined. Significant reductions occurred in the symptom-scores for runny nose, stuffy nose, sneezing, and nose blowing while patients were on cromolyn treatment (p less than 0.005). Likewise, while on treatment, there was a significant reduction in the consumption of antihistamines. In an attempt to differentiate between good and poor cromolyn responders by clinical and laboratory parameters, we found that (1) patients with high IgE levels responded better than those with low IgE levels, (2) patients with markedly positive skin test reactions to epidermoids and to foods responded better than those with pollen allergy, and (3) females appeared to have a significantly better drug response than males. Age did not play a role in drug response, nor did drug sequence (placebo-active or active-placebo).

Adolescent↗

PubMed1976

Papain inhibition by serum.

Sera from seven animal species (rat, cow, cat, dog, human, rabbit, and hamster) were tested and found to inhibit the papain-catalyzed hydrolysis of alpha-N-benzoyl-L-arginine-p-nitroaniline-HCl (L-BAPA). The relative concentration of inhibitor in each serum sample was expressed in terms of its papain inhibitory capacity (PIC) defined as the number of units of papain inhibited per ml of serum. Rat serum contained the highest concentration of inhibitor while hamster serum contained the lowest concentration. The inhibitor appears to be competitive with respect to L-BAPA and is heat labile and nondialyzable. Antipapain activity can be separated from antitrypsin activity by (NH4)2SO4 fractionation.

Ammonium Sulfate↗

PubMed1976

Two-year clinical evaluation of a pit and fissure sealant. Part II. Caries initiation and progression.

For the study, 479 paired permanent teeth and 20 paired deciduous teeth were coated under controlled clinical conditions with Nuva-Seal. A red dye was added to assist in placement and subsequent evaluation over a two-year period. Eighty-four children (ages 10 to 14) participated in the study. Caries was evaluated 3, 6, 12, and 24 months later with the same rating scale used at the baseline examination (0, caries free, to 4, severe caries), except when the sealant was found completely present and intact; then caries evaluation was limited to visual inspection through the sealant. The caries rate for control teeth was 6.9% at 3 months, 16.1% at 6 months, 26.4% at 12 months, and 37.6% at 24 months. Corresponding percent effectiveness figures for the sealant were 63.6%, 66.6%, 61.7%, and 54.6%, respectively. At 24 months, effectiveness rates for all types of teeth were at least 52% with the exception of the maxillary second molars (only 27% sealant effectiveness). Overall, caries protection as reflected by percent effectiveness was higher for mandibular teeth and premolars than for maxillary teeth and molars. There was significant effect on the incidence of dental caries when the sealant remained completely intact. Percentage effectiveness rates in this case were 90.7% at 12 months and 90.9% at 24 months. There was little gain or loss in caries protection when the sealant was partially or completely missing. Twenty-four percent of the children had a positive net gain or treatment effect at three months. This increased to 52% at 6 months, 62% at 12 months, and 70% at 24 months. With the use of half-mouth caries rates, the corresponding figures for positive treatment effects were slightly higher (30%, 64%, 70%, and 80% respectively).

Adolescent↗

PubMedDate not supplied

Epidural analgesia for postoperative pain control in children.

Ninety-eight continuous postoperative epidurals were administered to 87 children. The patients were divided into two groups: group I included 63 cases in which a 0.0625-0.25% solution of bupivacaine was continuously administered; group II included 35 cases in which a similar solution of bupivacaine mixed with 2-10 micrograms of fentanyl was administered. The dose of the epidural medication was titrated by the anesthesiologist according to the patient's age and anticipated level of postoperative pain. The average pain score for all patients for the first 48 h was 1.43. Supplemental analgesia averaging 0.132 mg intravenous morphine/kg/8 h was required in 49 cases (41 in group I and eight in group II). In group I, the average dose of supplemental analgesia was 0.144 mg intravenous morphine/kg/8 h, whereas in group II, it was only 0.056 mg intravenous morphine/kg/8 h. Continuous epidural analgesia is effective in controlling postoperative pain, and the addition of fentanyl reduces the need for systemic narcotics.

Adjuvants, Anesthesia↗